Lumefantrine,

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Lumefantrine has been used: to study its effect on ex-vivoPlasmodium falciparumsensitivity using the tritiated hypoxanthine-based assayas a standard in the quantification of combined tablet formulation using HPTLCas a drug molecule in in vitro growth inhibition assay for in vitro B. caballigrowth inhibition studies

Biochem/physiol Actions

Lumefantrine is is an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria.

Features and Benefits

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

General description

Lumefantrine, also known as benflumetol is an aryl-amino alcohol. It is a member of the group of arylamine alcohols like quinine, mefloquine and halofantrine.

Packaging

5, 25 mg in glass bottle